ADC Therapeutics
ADCT
ADCT
83 hedge funds and large institutions have $77.3M invested in ADC Therapeutics in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3.07% less ownership
Funds ownership: 58.43% → 55.36% (-3.1%)
31% less capital invested
Capital invested by funds: $112M → $77.3M (-$35.1M)
36% less call options, than puts
Call options by funds: $7K | Put options by funds: $11K
Holders
83
Holding in Top 10
2
Calls
$7K
Puts
$11K
Top Buyers
| 1 | +$719K | |
| 2 | +$600K | |
| 3 | +$228K | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$139K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$76.4K |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$1.32M | |
| 3 | -$504K | |
| 4 |
Millennium Management
New York
|
-$347K |
| 5 |
Two Sigma Investments
New York
|
-$195K |
